Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis. [Phase 2]
A Phase 2 clinical trial is evaluating Buloxibutid for efficacy and safety in idiopathic pulmonary fibrosis. The study is sponsored by Vicor…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF [Phase 3]
Phase 3 confirmatory trial of HEC585 tablets for idiopathic pulmonary fibrosis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis [Phase 1]
A Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of MNKD-201 in idiopathic pulmonary fibrosis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood [Phase 2]
A Phase 2 clinical trial in idiopathic pulmonary fibrosis is evaluating whether pirfenidone influences the blood concentration of BI-1015550…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast [Phase 3]
A Phase 3 follow-up trial is planned to assess long-term treatment with Nerandomilast in people with idiopathic pulmonary fibrosis or progre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment [Phase 2]
This update describes a Phase 2 clinical trial evaluating BI 765423 for its effect on lung function in idiopathic pulmonary fibrosis, with o…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis [Phase 3]
A Phase 3 clinical trial is evaluating metformin to slow respiratory decline in idiopathic pulmonary fibrosis. The study is currently not re…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of RC010 Inhalation Powder in Healthy Participants [Phase 1]
Phase 1 study to evaluate safety, tolerability and pharmacokinetics of RC010 inhalation powder in healthy participants, with idiopathic pulm…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis [Phase 3]
A Phase III multicenter randomized double-blind trial to evaluate the efficacy and safety of HSK44459 tablets in idiopathic pulmonary fibros…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis [Phase 2]
A Phase 2 clinical trial evaluating ABBV-142 in adults with idiopathic pulmonary fibrosis to assess adverse events and changes in disease ac…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial [NA]
The OPTIMIZE-ILD-1 trial aiming to optimize the diagnostic journey for interstitial lung disease is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial [NA]
The OPTIMIZE-ILD-2 trial aims to optimize follow-up care for interstitial lung disease and fibrotic ILD, and it is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis [Phase 2]
A Phase 2 clinical trial is evaluating the safe and effective dose of CHF10067 (Zampilimab) for idiopathic pulmonary fibrosis, sponsored by …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Validation of the C-mo System - Cough Monitoring [NA]
This clinical trial update concerns validation of the C-mo System for cough monitoring, with recruitment ongoing across conditions including…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF [Phase 2]
A Phase 2 randomized study is evaluating the safety and efficacy of AP02 (Nintedanib Solution) in idiopathic pulmonary fibrosis and is curre…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
A Phase 2 trial evaluating MTX-463 for Idiopathic Pulmonary Fibrosis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
This is a Phase 2 trial evaluating axatilimab for idiopathic pulmonary fibrosis and it is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis [Phase 3]
An ongoing Phase 3 trial is evaluating intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis. The study is cur…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
This clinical trial update indicates a Phase 2 study evaluating CAL101 for idiopathic pulmonary fibrosis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases. [NA]
A clinical trial is evaluating whether quercetin intake benefits patients with fibrotic interstitial lung diseases, including idiopathic pul…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers. [EARLY_Phase 1]
An early-phase 1 study evaluating the safety, tolerability, and pharmacokinetics of SV001 in Chinese healthy adult volunteers, with Idiopath…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD [NA]
Clinical trial update indicates expansion of pulmonary rehabilitation to treat chronic respiratory diseases beyond COPD, with the study curr…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Phase 1, Open-Label Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants [Phase 1]
Phase 1 open-label study to evaluate pharmacokinetics and potential drug-drug interactions of ENV-101 (taladegib) in healthy participants. I…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Phase Ia Clinical Trial of HW241045 [Phase 1]
A Phase 1 trial of HW241045 in healthy volunteers and idiopathic pulmonary fibrosis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: The relatıonshıp Between Upper Extremity Exercise Test and Exercise Capacity ın patıents wıth Idiopathic Pulmonary Fibrosis
This clinical trial update reports on the relationship between upper-extremity exercise tests and exercise capacity in patients with idiopat…